Home » Psychology news » Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD
Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD
April 4, 2019 by NewsBot
Neuroscientists have found that the psychedelic drug MDMA reopens a kind of window, called a 'critical period,' when the brain is sensitive to learning the reward value of social behaviors. The findings may explain why MDMA may be helpful in treating people with post-traumatic stress disorder (PTSD).